269 related articles for article (PubMed ID: 23596119)
1. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
Pillai V; Cibas ES; Dorfman DM
Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
[TBL] [Abstract][Full Text] [Related]
2. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B
Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402
[TBL] [Abstract][Full Text] [Related]
4. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B
Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls.
Dong HP; Holth A; Berner A; Davidson B; Risberg B
Cytometry B Clin Cytom; 2007 Sep; 72(5):332-43. PubMed ID: 17226863
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
[TBL] [Abstract][Full Text] [Related]
7. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
11. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
Sayed DM; el-Attar MM; Hussein AA
Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
Czader M; Ali SZ
Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
[TBL] [Abstract][Full Text] [Related]
16. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
19. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
[TBL] [Abstract][Full Text] [Related]
20. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
